posted on 2011-05-27, 00:00authored byGail S. Prins, Shu-Hua Ye, Lynn Birch, Shuk-mei Ho, Kurunthachalam Kannan
The present study examines BPA pharmacokinetics in neonatal rats following s.c. injection or oral delivery of 10g BPA/kg BW and compares susceptibility to estrogen-induced prostate intraepithelial neoplasia (PIN) following either exposure route. Serum BPA in PND3 rats was measured using HPLC-MS-MS. Free and total BPA at Cmax were 1.77 and 2.0 ng/ml, respectively following injection and 0.26 and 1.02 ng/ml, respectively following oral exposure. The AUC0-2 for free and total BPA was 4.1-fold and 1.8-fold greater, respectively, in s.c. versus oral delivery. While exposure route affected BPA metabolism, internal dosimetry following s.c. injection of 10g BPA/kg BW is similar to BPA levels observed in humans. Prostates from aged rats given s.c. or oral BPA neonatally and T+E implants as adults exhibited nearly identical, heightened susceptibility to PIN incidence and score as compared to neonatal oil-controls. These findings on prostate health are directly relevant to humans at current BPA exposure levels.
Funding
Supported by NIH grant ES-015584 with supplemental NIH funding from American Recovery and Reinvestment Act.
History
Publisher Statement
NOTICE: this is the author’s version of a work that was accepted for publication in Reproductive Toxicology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Reproductive Toxicology, [Vol 31, Issue 1, (January 2011)] DOI: 10.1016/j.reprotox.2010.09.009. The original publication is available at www.elsevier.com.